Yale professor part of nationwide Alzheimer’s disease study looking for participants

The New haven Register is reporting that "A nationwide study is testing two medications that may prevent Alzheimer’s disease in those at risk for the devastating illness.

Dr. Christopher Van Dyck, a professor of psychiatry and neurology at the Yale School of Medicine and director of the Alzheimer’s Disease Research Unit, is among those conducting the study at more than 90 sites.

“This is part of a nationwide prevention trial of very, very large scale,” Van Dyck said Tuesday. “It’s far and away the biggest (study of) genetic risk or inherited risk.”

Researchers are looking for people 60 to 75 years old who have two copies of the e4 type of the apolipoprotein gene. Known as APOE 4/4, it is seen as a high risk factor for Alzheimer’s in older patients."

To read the full article, read HERE.